Last $31.42 USD
Change Today -0.03 / -0.10%
Volume 10.8M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 5:15 PM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank A. D'Amelio

Chief Financial Officer and Executive Vice President of Business Operations, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 7 different industries.

See Board Relationships
57$7,124,330
As of Fiscal Year 2013

Background*

Mr. Frank A. D'Amelio has been the Chief Financial Officer of Pfizer Inc., since August 2007 and has also been its Executive Vice President of Business Operations since December 2010. He is the Executive Vice President of Business Operations and Chief Financial Officer at Thiakis Limited. Mr. D'Amelio has three decades of an extensive operating and financial experience. Mr. D'Amelio served as Senior Vice President of Business Operations at Pfizer Inc., from August 2007 ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Former Chief Operating Officer and Director
Director
2003-Present
Director, Chairman of Audit Committee and Member of Investment Committee
2012-Present
Director and Member of Corporate Governance Committee

Education*

MBA
St. John's University
Bachelor's Degree
Saint Peter's University

Other Affiliations*

Annual Compensation*

Salary$1,243,750
Total Annual Compensation$1,243,750

Stock Options*

Restricted Stock Awards$1,937,522
All Other Compensation$235,655
Exercisable Options292,000
Exercisable Options Value$1,810,400
Total Value of Options$1,810,400
Total Number of Options292,000

Total Compensation*

Total Annual Cash Compensation$3,129,405
Total Short Term Compensation$1,243,750
Other Long Term Compensation$2,173,177
Total Calculated Compensation$7,124,330
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $31.42 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Joseph Jimenez MBAChief Executive Officer and Member of Executive Committee
Novartis AG
SFr.3.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.